These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8689648

  • 1. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats.
    Sladek T, Sladkova J, Kolar F, Papousek F, Cicutti N, Korecky B, Rakusan K.
    Cardiovasc Res; 1996 Apr; 31(4):568-76. PubMed ID: 8689648
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of doxycycline, losartan, and their combination in the prevention of post-infarction remodeling in rats].
    Yang YJ, Zhang P, Ruan YM, Chen X, Zhou YW, Tian Y, Gao RL, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):479-85. PubMed ID: 16178444
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
    Van Kerckhoven R, van Veghel R, Saxena PR, Schoemaker RG.
    Cardiovasc Res; 2004 Feb 15; 61(3):620-9. PubMed ID: 14962492
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
    El-Sabban ME, Hassan KA, Birbari AE, Bitar KM, Bikhazi AB.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 15; 1(4):369-78. PubMed ID: 11967826
    [Abstract] [Full Text] [Related]

  • 5. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Wada K, Fujimori A, Matsukawa U, Arai Y, Sudoh K, Yatsu T, Sasamata M, Miyata K.
    Eur J Pharmacol; 2005 Jan 10; 507(1-3):145-51. PubMed ID: 15659304
    [Abstract] [Full Text] [Related]

  • 6. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG, Reinecke A, Dorenkamp M, Storz C, Bitterling H, Penz S, Cleutjens J, Daemen MJ, Simon R, Unger T.
    Acta Pharmacol Sin; 2004 Jun 10; 25(6):763-8. PubMed ID: 15169629
    [Abstract] [Full Text] [Related]

  • 7. Regional changes in angiotensin II receptor density after experimental myocardial infarction.
    Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RA, Suzuki T, Morgan K, Polak JM, Poole-Wilson PA.
    J Mol Cell Cardiol; 1996 Feb 10; 28(2):429-40. PubMed ID: 8729073
    [Abstract] [Full Text] [Related]

  • 8. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A, Henegar JR, Devineni VR, Janicki JS.
    Cardiovasc Res; 1995 Apr 10; 29(4):543-8. PubMed ID: 7796449
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H.
    Circulation; 1994 May 10; 89(5):2273-82. PubMed ID: 8181153
    [Abstract] [Full Text] [Related]

  • 10. Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction.
    Zhu YZ, Zhu YC, Li J, Schäfer H, Schmidt W, Yao T, Unger T.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep 10; 1(3):257-62. PubMed ID: 11881034
    [Abstract] [Full Text] [Related]

  • 11. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB, Qiu CS, Hess P, Clozel JP, Clozel M.
    Acta Pharmacol Sin; 2001 Jun 10; 22(6):541-8. PubMed ID: 11747762
    [Abstract] [Full Text] [Related]

  • 12. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
    van Veldhuisen DJ, Brodde OE, van Gilst WH, Schulze C, Hegeman H, Anthonio RL, Scholtens E, de Graeff PA, Wesseling H, Lie KI.
    Cardiovasc Res; 1995 Sep 10; 30(3):386-93. PubMed ID: 7585830
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S, Li J, Fritzenkötter C, Spormann J, Tiede K, Fischer JW, Unger T.
    Blood Press; 2006 Sep 10; 15(2):116-28. PubMed ID: 16754275
    [Abstract] [Full Text] [Related]

  • 14. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.
    Diaz RJ, Wilson GJ.
    J Mol Cell Cardiol; 1997 Jan 10; 29(1):129-39. PubMed ID: 9040028
    [Abstract] [Full Text] [Related]

  • 15. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840
    [Abstract] [Full Text] [Related]

  • 16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 30; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K, Gottlieb S, Fleck E, Kostis J, Levine B, DeKock M, LeJemtel T.
    J Hypertens Suppl; 1994 Jul 30; 12(2):S31-5. PubMed ID: 7965263
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.
    Baba HA, Iwai T, Bauer M, Irlbeck M, Schmid KW, Zimmer HG.
    J Mol Cell Cardiol; 1999 Feb 30; 31(2):445-55. PubMed ID: 10093056
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
    Hayashi N, Fujimura Y, Yamamoto S, Kometani M, Nakao K.
    Arzneimittelforschung; 1997 May 30; 47(5):625-9. PubMed ID: 9205776
    [Abstract] [Full Text] [Related]

  • 20. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M, Suzuki H, Naitoh M, Matsumoto A, Kageyama Y, Tsujimoto G, Saruta T.
    J Hypertens; 1995 Dec 30; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.